CymaBay Therapeutics Inc. (CBAY) Social Stream



CymaBay Therapeutics Inc. (CBAY): $3.81

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CBAY to Watchlist
Sign Up

Industry: Biotech


Ranked

of 508

in industry

Featured Post From StockTwits About CBAY

$CBAY Focused on Seladelpar. Increase in expenses due to prep for launch of Seladelpar. Recent funding is specifically to get the drug “across the finish line”. They had many available options for capital and considered share holder value when making the decision. Covid delays likely to continue only negative I heard. Going to hold an analyst day in November. I’m going to keep accumulating cheap shares.
The_Flying_Janitor, published August 12, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.714 seconds.